After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
NVCR belongs to the Healthcare sector of the NASDAQ while operating in the Medical Devices industry. The current market capitalization of NovoCure Ltd is $1.22B. A total of 1.39 million shares were traded on the day, compared to an average of 1.63M shares.
In the most recent transaction, Brackmann Christoph bought 20,000 shares of NVCR for 11.59 per share on Jul 29 ’25. After the transaction, the Chief Financial Officer now owns 141,150 company shares. In a previous transaction on Jun 03 ’25, Stafford Kristin sold 999 shares at 17.28 per share. NVCR shares that Director owns now total 3,054.
Among the insiders who sold shares, LEUNG GABRIEL disposed of 999 shares on Jun 03 ’25 at a per-share price of $17.31. This resulted in the Director holding 81,229 shares of NVCR after the transaction. In another insider transaction, Madden Martin J. sold 999 shares at $17.19 per share on Jun 03 ’25. Company shares held by the Director now total 18,674.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NVCR has a high of $34.13 and a low of $10.91.
As of this writing, NVCR has an earnings estimate of -$0.42 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.38 per share and a lower estimate of -$0.48. The company reported an EPS of -$0.28 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NVCR’s latest balance sheet shows that the firm has $937.70M in Cash & Short Term Investments as of fiscal 2021. There were $575.21M in debt and $142.60M in liabilities at the time. Its Book Value Per Share was $3.13, while its Total Shareholder’s Equity was $410.49M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVCR is Buy with a score of 4.25.
